Cited by 424Dermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisContact Dermatitis and Allergies

The DOI matches its Crossref record; 226 of the 231 references it cites were found in a registry or an index.

Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis

Open access

Furue, Masutaka·2020·International Journal of Molecular Sciences

Open this paper in CoChat — free account Open PDF

Abstract

Atopic dermatitis (AD) is an eczematous, pruritic skin disorder with extensive barrier dysfunction and elevated interleukin (IL)-4 and IL-13 signatures. The barrier dysfunction correlates with the downregulation of barrier-related molecules such as filaggrin (FLG), loricrin (LOR), and involucrin (IVL). IL-4 and IL-13 potently inhibit the expression of these molecules by activating signal transducer and activator of transcription (STAT)6 and STAT3. In addition to IL-4 and IL-13, IL-22 and IL-17A are probably involved in the barrier dysfunction by inhibiting the expression of these barrier-related molecules. In contrast, natural or medicinal ligands for aryl hydrocarbon receptor (AHR) are potent upregulators of FLG, LOR, and IVL expression. As IL-4, IL-13, IL-22, and IL-17A are all capable of inducing oxidative stress, antioxidative AHR agonists such as coal tar, glyteer, and tapinarof exert particular therapeutic efficacy for AD. These antioxidative AHR ligands are known to activate an antioxidative transcription factor, nuclear factor E2-related factor 2 (NRF2). This article focuses on the mechanisms by which FLG, LOR, and IVL expression is regulated by IL-4, IL-13, IL-22, and IL-17A. The author also summarizes how AHR and NRF2 dual activators exert their beneficial effects in the treatment of AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3390/ijms21155382

Cites

226 of 226 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: Overexpression of macrophage stimulating 1 enhances the anti-tumor effects of IL-24 in esophageal cancer via inhibiting ERK-Mfn2 signaling-dependent mitophagy
Zhang, J., Sun, L., Li, W., Wang, Y., Li, X., & Liu, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108844 · Cited by 15
Retracted
Diagnostic features of atopic dermatitis
Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis
Palmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1767 · Cited by 2,978
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610020 · Cited by 2,110
The skin: an indispensable barrier
Proksch, E., Brandner, J. M., & Jensen, J. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00786.x · Cited by 2,054
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
IL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,406
Cytokine modulation of atopic dermatitis filaggrin skin expression
Howell, M. D., Kim, B. E., Gao, P., Grant, A. V., Boguniewicz, M., DeBenedetto, A., Schneider, L., Beck, L. A., Barnes, K. C., & Leung, D. Y. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.031 · Cited by 1,084
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris
Smith, F. J. D., Irvine, A. D., Terron-Kwiatkowski, A., Sandilands, A., Campbell, L., Zhao, Y., Liao, H., Evans, A. T., Goudie, D. R., Lewis‐Jones, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1743 · Cited by 1,026
Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
Gittler, J. K., Shemer, A., Suárez-Fariñas, M., Fuentes-Duculan, J., Gulewicz, K. J., Wang, C. Q. F., Mitsui, H., Cardinale, I., de Guzman Strong, C., Krueger, J. G., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.012 · Cited by 981
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Gordon, K. B., Blauvelt, A., Papp, K. A., Langley, R. G. B., Luger, T. A., Ohtsuki, M., Reich, K., Amato, D. A., Ball, S. G., Braun, D. K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512711 · Cited by 867
IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes
Boniface, K., Bernard, F.-X., Garcia, M., Gurney, A. L., Lecron, J.-C., & Morel, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3695 · Cited by 864
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Lebwohl, M., Strober, B. E., Menter, A., Gordon, K. B., Węgłowska, J., Puig, L., Papp, K. A., Spelman, L. J., Toth, D. P., Kerdel, F. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503824 · Cited by 830
Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways
Nograles, K. E., Zaba, L. C., Guttman‐Yassky, E., Fuentes‐Duculan, J., Suárez‐Fariñas, M., Cardinale, I. R., Khatcherian, A., Gonzalez, J., Pierson, K. C., White, T. R., et al. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08769.x · Cited by 816
AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch
Lee, J. S., Cella, M., McDonald, K. G., Garlanda, C., Kennedy, G. D., Nukaya, M., Mantovani, A., Kopan, R., Bradfield, C. A., Newberry, R. D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2187 · Cited by 777
Functional role of AhR in the expression of toxic effects by TCDD
Mimura, J., & Fujii‐Kuriyama, Y. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00485-3 · Cited by 754
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Guttman‐Yassky, E., Bissonnette, R., Ungar, B., Suárez‐Fariñas, M., Ardeleanu, M., Esaki, H., Suprun, M., Estrada, Y. D., Xu, H., Peng, X., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.08.022 · Cited by 715
Tuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes
Junttila, I. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00888 · Cited by 687
Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis
Chiricozzi, A., Guttman-Yassky, E., Suárez-Fariñas, M., Nograles, K. E., Tian, S., Cardinale, I., Chimenti, S., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.340 · Cited by 686
IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells
Nograles, K. E., Zaba, L. C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., Ramon, M., Bergman, R., Krueger, J. G., & Guttman-Yassky, E. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.041 · Cited by 627
Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis
Paternoster, L., Kemp, J. P., Zheng, J., Smith, G. D., Relton, C. L., Evans, D. M., McArdle, W. L., Henderson, A. J., Standl, M., Tiesler, C. M. T., et al. (2015) · Nature Genetics · doi:10.1038/ng.3424 · Cited by 620
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
Kim, B. E., Leung, D. Y. M., Boguniewicz, M., & Howell, M. D. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.11.006 · Cited by 538
The aryl hydrocarbon receptor as a target of environmental stressors – Implications for pollution mediated stress and inflammatory responses
Vogel, C. F. A., Winkle, L. S. V., Esser, C., & Haarmann‐Stemmann, T. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101530 · Cited by 538
The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis
Susan, M. L., Valdez, P. A., Wu, J., Jung, K., Zhong, F., Hall, L., Kasman, I. M., Winer, J., Modrusan, Z. D., Danilenko, D. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2229 · Cited by 519
Basic biology and role of interleukin‐17 in immunity and inflammation
Zenobia, C., & Hajishengallis, G. (2015) · Periodontology 2000 · doi:10.1111/prd.12083 · Cited by 507
Genes Encoding Structural Proteins of Epidermal Cornification and S100 Calcium-Binding Proteins Form a Gene Complex (“Epidermal Differentiation Complex”) on Human Chromosome 1q21
Mischke, D., Korge, B. P., Marenholz, I., Volz, A., & Ziegler, A. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12338501 · Cited by 505
The Aryl Hydrocarbon Receptor in Barrier Organ Physiology, Immunology, and Toxicology
Esser, C., & Rannug, A. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009001 · Cited by 501
Interleukin-22 (IL-22) Activates the JAK/STAT, ERK, JNK, and p38 MAP Kinase Pathways in a Rat Hepatoma Cell Line
Lejeune, D., Dumoutier, L., Constantinescu, S. N., Kruijer, W., Schuringa, J. J., & Renauld, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204204200 · Cited by 499
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Brembilla, N. C., Senra, L., & Boehncke, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01682 · Cited by 491
Pathogenesis of psoriasis and development of treatment
Ogawa, E., Sato, Y., Minagawa, A., & Okuyama, R. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14139 · Cited by 470
Atopic Dermatitis Is an IL-13–Dominant Disease with Greater Molecular Heterogeneity Compared to Psoriasis
Tsoi, L. C., Rodriguez, E., Degenhardt, F., Baurecht, H., Wehkamp, U., Volks, N., Szymczak, S., Swindell, W. R., Sarkar, M. K., Raja, K., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.12.018 · Cited by 469
Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation
Fritsche, E., Schäfer, C., Calles, C., Bernsmann, T., Bernshausen, T., Wurm, M., Hübenthal, U., Cline, J. E., Hajimiragha, H., Schroeder, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701764104 · Cited by 437
Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin
Esaki, H., Brunner, P. M., Renert-Yuval, Y., Czarnowicki, T., Huynh, T., Tran, G., Lyon, S., Rodriguez, G., Immaneni, S., Johnson, D. B., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.013 · Cited by 428
Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb
Wollenberg, A., Howell, M. D., Guttman‐Yassky, E., Silverberg, J. I., Kell, C., Ranade, K., Moate, R., & van der Merwe, R. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.05.029 · Cited by 408
Significance of Skin Barrier Dysfunction in Atopic Dermatitis
Kim, B. E., & Leung, D. Y. M. (2018) · Allergy, Asthma & Immunology Research · doi:10.4168/aair.2018.10.3.207 · Cited by 393
Periostin promotes chronic allergic inflammation in response to Th2 cytokines
増岡, 美., Shiraishi, H., Ohta, S., Suzuki, S., Arima, K., Aoki, S., Toda, S., Inagaki, N., Kurihara, Y., Hayashida, S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58978 · Cited by 392
Self-citation
Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans.
Smith, S. H., Jayawickreme, C., Rickard, D. J., Nicodeme, E., Bui, T., Simmons, C., Coquery, C. M., Neil, J., Pryor, W. M., Mayhew, D., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.05.004 · Cited by 387
Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis
van den Bogaard, E. H., Bergboer, J. G. M., Vonk-Bergers, M., van Vlijmen-Willems, I. M. J. J., Hato, S. V., van der Valk, P. G. M., Schröder, J. M., Joosten, I., Zeeuwen, P. L. J. M., & Schalkwijk, J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65642 · Cited by 373
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
Guttman-Yassky, E., Brunner, P. M., Neumann, A. U., Khattri, S., Pavel, A. B., Malik, K., Singer, G. K., Baum, D., Gilleaudeau, P., Sullivan-Whalen, M., et al. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.01.016 · Cited by 343
IL‐17 and IL‐22 in immunity: Driving protection and pathology
Eyerich, K., Dimartino, V., & Cavani, A. (2017) · European Journal of Immunology · doi:10.1002/eji.201646723 · Cited by 339
The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the ‘fused genes’ family
Kypriotou, M., Huber, M., & Hohl, D. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01472.x · Cited by 338
Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies
Furue, M., Chiba, T., Tsuji, G., Ulzii, D., Kido‐Nakahara, M., Nakahara, T., & Kadono, T. (2017) · Allergology International · doi:10.1016/j.alit.2016.12.002 · Cited by 324
Self-citation
Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis
Jensen, J.-M., Fölster-Holst, R., Baranowsky, A., Schunck, M., Winoto-Morbach, S., Neumann, C., Schütze, S., & Proksch, E. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22621.x · Cited by 309
Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis
Nomura, T., Sandilands, A., Akiyama, M., Liao, H., Evans, A. T., Sakai, K., Ota, M., Sugiura, H., Yamamoto, K., Satō, H., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.12.646 · Cited by 272
A tryptophan metabolite of the skin microbiota attenuates inflammation in patients with atopic dermatitis through the aryl hydrocarbon receptor
Yu, J., Luo, Y., Zhu, Z., Zhou, Y., Sun, L., Gao, J., Sun, J., Wang, G., Yao, X., & Li, W. S. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.11.036 · Cited by 262
The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling
Amano, W., Nakajima, S., Kunugi, H., Numata, Y., Kitoh, A., Egawa, G., Dainichi, T., Honda, T., Otsuka, A., Kimoto, Y., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.03.051 · Cited by 259
Assembly of the epidermal cornified cell envelope
Kalinin, A., Marekov, L. N., & Steinert, P. M. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.17.3069 · Cited by 250
Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin
Pellerin, L., Henry, J., Hsu, C.-Y., Balica, S., Jean-Decoster, C., Méchin, M.-C., Hansmann, B., Rodriguez, E., Weindinger, S., Schmitt, A.-M., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1566 · Cited by 239
IL‐17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion
Gutowska‐Owsiak, D., Schaupp, A., Salimi, M., Selvakumar, T. A., McPherson, T., Taylor, S., & Ogg, G. S. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01412.x · Cited by 235
The Antimicrobial Protein Psoriasin (S100A7) Is Upregulated in Atopic Dermatitis and after Experimental Skin Barrier Disruption
Gläser, R., Meyer‐Hoffert, U., Harder, J., Cordes, J., Wittersheim, M., Kobliakova, J., Fölster‐Holst, R., Proksch, E., Schröder, J., & Schwarz, T. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.268 · Cited by 217
Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
Furue, M., Hashimoto-Hachiya, A., & Tsuji, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215424 · Cited by 215
Self-citation
Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)+ TH2/TH1 cell imbalance, whereas adults acquire CLA+ TH22/TC22 cell subsets
Czarnowicki, T., Esaki, H., Gonzalez, J., Malajian, D., Shemer, A., Noda, S., Talasila, S., Berry, A., Gray, J., Becker, L., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.049 · Cited by 211
An environmental contaminant, benzo(a)pyrene, induces oxidative stress-mediated interleukin-8 production in human keratinocytes via the aryl hydrocarbon receptor signaling pathway
Tsuji, G., Takahara, M., Uchi, H., Takeuchi, S., Mitoma, C., Moroi, Y., & Furue, M. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.10.017 · Cited by 209
Self-citation
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab
Brunner, P. M., Pavel, A. B., Khattri, S., Leonard, A., Malik, K., Rose, S., On, S. C. J., Vekaria, A. S., Traidl‐Hoffmann, C., Singer, G., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.07.028 · Cited by 204
The hsp90 Chaperone Complex Regulates Intracellular Localization of the Dioxin Receptor
Kazlauskas, A., Sundström, S., Poellinger, L., & Pongratz, I. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.7.2594-2607.2001 · Cited by 202
IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis
Krueger, J. G., Wharton, K. A., Schlitt, T., Suprun, M., Torene, R. I., Jiang, X., Wang, C. Q. F., Fuentes‐Duculan, J., Hartmann, N., Peters, T., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.04.029 · Cited by 193
Nrf2-A regulator of keratinocyte redox signaling
Schäfer, M., & Werner, S. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.018 · Cited by 192
Nrf2 links epidermal barrier function with antioxidant defense
Schäfer, M., Farwanah, H., Willrodt, A., Huebner, A. J., Sandhoff, K., Roop, D. R., Hohl, D., Bloch, W., & Werner, S. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200219 · Cited by 191
Structure of IL-22 Bound to Its High-Affinity IL-22R1 Chain
Jones, B. C., Logsdon, N. J., & Walter, M. R. (2008) · Structure · doi:10.1016/j.str.2008.06.005 · Cited by 185
IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
Chiricozzi, A., Nograles, K. E., Johnson-Huang, L. M., Fuentes‐Duculan, J., Cardinale, I. R., Bonifacio, K. M., Gulati, N., Mitsui, H., Guttman‐Yassky, E., Suárez‐Fariñas, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090284 · Cited by 182
Chronic mucocutaneous candidiasis disease associated with inborn errors of IL‐17 immunity
Okada, S., Puel, A., Casanova, J., & Kobayashi, M. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.71 · Cited by 179
Decreased expression of filaggrin in atopic skin
Seguchi, T., Chang-Yi, C., Kusuda, S., Takahashi, M., Aisu, K., & Tezuka, T. (1996) · Archives of Dermatological Research · doi:10.1007/bf02505232 · Cited by 175
Role of AhR/ARNT system in skin homeostasis
Furue, M., Takahara, M., Nakahara, T., & Uchi, H. (2014) · Archives of Dermatological Research · doi:10.1007/s00403-014-1481-7 · Cited by 175
Self-citation
Malassezia Yeasts Produce a Collection of Exceptionally Potent Activators of the Ah (Dioxin) Receptor Detected in Diseased Human Skin
Magiatis, P., Pappas, P., Gaitanis, G., Mexia, N., Melliou, E., Galanou, M., Vlachos, C., Stathopoulou, K., Skaltsounis, A., Μαρσέλος, Μ., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.92 · Cited by 172
Nrf2 Promotes Keratinocyte Proliferation in Psoriasis through Up-Regulation of Keratin 6, Keratin 16, and Keratin 17
Yang, L., Fan, X., Cui, T., Dang, E., & Wang, G. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.05.015 · Cited by 171
Identification of Ketoconazole as an AhR-Nrf2 Activator in Cultured Human Keratinocytes: The Basis of Its Anti-Inflammatory Effect
Tsuji, G., Takahara, M., Uchi, H., Matsuda, T., Chiba, T., Takeuchi, S., Yasukawa, F., Moroi, Y., & Furue, M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.194 · Cited by 169
Self-citation
Interleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes: IL-22 affects filaggrin expression at multiple levels
Gutowska-Owsiak, D., Schaupp, A. L., Salimi, M., Taylor, S., & Ogg, G. S. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10400.x · Cited by 168
IL-19 Is a Component of the Pathogenetic IL-23/IL-17 Cascade in Psoriasis
Witte, E., Kokolakis, G., Witte, K., Philipp, S., Doecke, W., Babel, N., Wittig, B. M., Warszawska, K., Kurek, A., Erdmann‐Keding, M., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.308 · Cited by 168
Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways
Galbraith, G. M. P. (2009) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(09)79289-5 · Cited by 167
A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis
Peppers, J., Paller, A. S., Maeda-Chubachi, T., Wu, S., Robbins, K., Gallagher, K., & Kraus, J. E. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.06.047 · Cited by 165
Ultraviolet-B Exposure of Human Skin Induces Cytochromes P450 1A1 and 1B1
Katiyar, S. K., Mukhtar, H., & Matsui, M. S. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00876.x · Cited by 158
Response of murine epidermis to 2,3,7,8-tetrachlorodibenzo-p-dioxin: Interaction of the Ah and hr loci
Knutson, J. C. (1982) · Cell · doi:10.1016/0092-8674(82)90028-9 · Cited by 156
IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway
Cho, K., Suh, J. W., Lee, K. H., Kang, J. L., & Woo, S. (2011) · International Immunology · doi:10.1093/intimm/dxr110 · Cited by 155
Identification of an anthraquinone pigment and a hydroxystilbene antibiotic from Xenorhabdus luminescens
Richardson, W. H., Schmidt, T. M., & Nealson, K. H. (1988) · Applied and Environmental Microbiology · doi:10.1128/aem.54.6.1602-1605.1988 · Cited by 153
Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation
Su, Y., Huang, J., Zhao, X., Li, J., Wang, W., Yang, X. O., Shi, Y., Wang, X., Lai, Y., & Dong, C. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau9657 · Cited by 151
Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis
Tsuji, G., Hashimoto-Hachiya, A., Kiyomatsu-Oda, M., Takemura, M., Ohno, F., Ito, T., Morino-Koga, S., Mitoma, C., Nakahara, T., Uchi, H., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.322 · Cited by 149
Self-citation
Fluorescence Excitation Spectroscopy Provides Information About Human Skin In Vivo
Gillies, R. J., Zonios, G. I., Anderson, R. R., & Kollias, N. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00091.x · Cited by 142
Safety of biologics in psoriasis
Kamata, M., & Tada, Y. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14096 · Cited by 133
Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization
Broccardo, C. J., Mahaffey, S. B., Schwarz, J., Wruck, L. M., David, G. L., Schlievert, P. M., Reisdorph, N. A., & Leung, D. Y. M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.033 · Cited by 132
Gene regulation of filaggrin and other skin barrier proteins via aryl hydrocarbon receptor
Furue, M., Tsuji, G., Mitoma, C., Nakahara, T., Chiba, T., Morino-Koga, S., & Uchi, H. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.07.011 · Cited by 132
Self-citation
The IL ‐13/periostin/ IL ‐24 pathway causes epidermal barrier dysfunction in allergic skin inflammation
Mitamura, Y., Nunomura, S., Nanri, Y., Ogawa, M., Yoshihara, T., 増岡, 美., Tsuji, G., Nakahara, T., Hashimoto‐Hachiya, A., Conway, S. J., et al. (2018) · Allergy · doi:10.1111/all.13437 · Cited by 132
Self-citation
Molecular Identification and Expression Analysis of Filaggrin-2, a Member of the S100 Fused-Type Protein Family
Wu, Z., Hansmann, B., Meyer‐Hoffert, U., Gläser, R., & Schröder, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005227 · Cited by 128
2,3,7,8-Tetrachlorodibenzo-p-dioxin increases reactive oxygen species production in human endothelial cells via induction of cytochrome P4501A1
Kopf, P. G., & Walker, M. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.02.007 · Cited by 127
Chloracne, "the hallmark of dioxin intoxication".
Suskind, R. R. (1985) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.2240 · Cited by 127
Interleukin-4 and interferon-γ orchestrate an epithelial polarization in the airways
Zissler, U. M., Chaker, A. M., Effner, R., Ulrich, M., Guerth, F. M., Piontek, G., Dietz, K., Regn, M., Knapp, B. L., Theis, F. J., et al. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.110 · Cited by 126
Ovol1 regulates the growth arrest of embryonic epidermal progenitor cells and represses c-myc transcription
Nair, M., Teng, A., Bilanchone, V., Agrawal, A., Li, B., & Dai, X. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200508196 · Cited by 125
Pathogenesis of Atopic Dermatitis: Current Paradigm.
Furue, M., Ulzii, D., Vu, Y. H., Tsuji, G., Kido‐Nakahara, M., & Nakahara, T. (2019) · PubMed · doi:10.22034/iji.2019.80253 · Cited by 123
Self-citation
PTP1B is a negative regulator of interleukin 4–induced STAT6 signaling
Lu, X., Malumbres, R., Shields, B., Jiang, X., Sarosiek, K. A., Natkunam, Y., Tiganis, T., & Lossos, I. S. (2008) · Blood · doi:10.1182/blood-2008-03-148726 · Cited by 122
Interleukin‐17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities
Krueger, J. G., & Brunner, P. M. (2017) · Experimental Dermatology · doi:10.1111/exd.13467 · Cited by 118
Interleukin-22: A likely target for treatment of autoimmune diseases
Yang, X., & Zheng, S. G. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.11.008 · Cited by 116
Receptors for Interleukin (IL)-4 Do Not Associate with the Common γChain, and IL-4 Induces the Phosphorylation of JAK2 Tyrosine Kinase in Human Colon Carcinoma Cells
Murata, T., Noguchi, P. D., & Puri, R. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30829 · Cited by 115
Antioxidants for Healthy Skin: The Emerging Role of Aryl Hydrocarbon Receptors and Nuclear Factor-Erythroid 2-Related Factor-2
Furue, M., Uchi, H., Mitoma, C., Hashimoto-Hachiya, A., Chiba, T., Ito, T., Nakahara, T., & Tsuji, G. (2017) · Nutrients · doi:10.3390/nu9030223 · Cited by 113
Self-citation
Regulation of CYP1A1 Transcription via the Metabolism of the Tryptophan-Derived 6-Formylindolo[3,2-b]carbazole
Wei, Y., Bergander, L. V., Rannug, U., & Rannug, A. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2037 · Cited by 110
Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression
Otsuka, A., Doi, H., Egawa, G., Maekawa, A., Fujita, T., Nakamizo, S., Nakashima, C., Nakajima, S., Watanabe, T., Miyachi, Y., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.027 · Cited by 108
Genetic and Pharmacological Analysis Identifies a Physiological Role for the AHR in Epidermal Differentiation
van den Bogaard, E. H. J., Podolsky, M. A., Smits, J. P. H., Cui, X., John, C., Gowda, K., Desai, D. H., Amin, S., Schalkwijk, J., Perdew, G. H., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.6 · Cited by 107
Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 Study
Gordon, K. B., Armstrong, A. W., Foley, P. A., Song, M., Shen, Y., Li, S., Muñoz‐Elías, E. J., Branigan, P. J., Liu, X., & Reich, K. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.05.016 · Cited by 107
The IL ‐13– OVOL 1– FLG axis in atopic dermatitis
Furue, K., Ito, T., Tsuji, G., Ulzii, D., Vu, Y. H., Kido‐Nakahara, M., Nakahara, T., & Furue, M. (2019) · Immunology · doi:10.1111/imm.13120 · Cited by 107
Self-citation
Defining the Role for XAP2 in Stabilization of the Dioxin Receptor
Lees, M. J., Peet, D. J., & Whitelaw, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302430200 · Cited by 105
IL‐17 and IL‐22 mediate IL‐20 subfamily cytokine production in cultured keratinocytes via increased IL‐22 receptor expression
Tohyama, M., Hanakawa, Y., Shirakata, Y., Dai, X., Yang, L., Hirakawa, S., Tokumaru, S., Okazaki, H., Sayama, K., & Hashimoto, K. (2009) · European Journal of Immunology · doi:10.1002/eji.200939473 · Cited by 104
Staphylococcus aureus in atopic dermatitis: Strain-specific cell wall proteins and skin immunity
Iwamoto, K., Moriwaki, M., Miyake, R., & Hide, M. (2019) · Allergology International · doi:10.1016/j.alit.2019.02.006 · Cited by 104
Redox Regulation of Interleukin-4 Signaling
Sharma, P., Chakraborty, R., Wang, L., Min, B., Tremblay, M. L., Kawahara, T., Lambeth, J. D., & Haque, S. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.019 · Cited by 103
Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway
Murata, T. (1998) · International Immunology · doi:10.1093/intimm/10.8.1103 · Cited by 101
2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated production of reactive oxygen species is an essential step in the mechanism of action to accelerate human keratinocyte differentiation
Kennedy, L. H., Sutter, C. H., Leon Carrion, S., Tran, Q. T., Bodreddigari, S., Kensicki, E., Mohney, R. P., & Sutter, T. R. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kfs325 · Cited by 100
Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model
Palombo, R., Savini, I., Avigliano, L., Madonna, S., Cavani, A., Albanesi, C., Mauriello, A., Melino, G., & Terrinoni, A. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.201 · Cited by 99
Activation of Nrf2 in keratinocytes causes chloracne (MADISH)-like skin disease in mice
Schäfer, M., Willrodt, A., Kurinna, S., Link, A. S., Farwanah, H., Geusau, A., Gruber, F., Sorg, O., Huebner, A. J., Roop, D. R., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303281 · Cited by 98
Signal Transduction Pathway of Interleukin-4 and Interleukin-13 in Human B Cells Derived from X-linked Severe Combined Immunodeficiency Patients
Izuhara, K., Heike, T., Otsuka, T., Yamaoka, K., Mayumi, M., Imamura, T., Niho, Y., & Harada, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.619 · Cited by 97
EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes
Sutter, T. R., Yin, H., Li, Y., Mammen, J. S., Bodreddigari, S., Stevens, G., Cole, J. A., & Sutter, T. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900874106 · Cited by 97
Transient Expression of Epidermal Filaggrin in Cultured Cells Causes Collapse of Intermediate Filament Networks with Alteration of Cell Shape and Nuclear Integrity.
Dale, B. A., Presland, R. B., Lewis, S. P., Underwood, R. A., & Fleckman, P. H. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12334205 · Cited by 94
Filaggrin failure - from ichthyosis vulgaris to atopic eczema and beyond
McLean, W. H. I. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14997 · Cited by 94
UV-induced CYP1A1 gene expression in human cells is mediated by tryptophan
Wei, Y., Rannug, U., & Rannug, A. (1999) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(98)00118-5 · Cited by 93
2,3,7,8-Tetrachlorodibenzo-p-dioxin increases the expression of genes in the human epidermal differentiation complex and accelerates epidermal barrier formation
Sutter, C. H., Bodreddigari, S., Campion, C., Wible, R. S., & Sutter, T. R. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr205 · Cited by 93
Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis
Robbins, K., Bissonnette, R., Maeda‐Chubachi, T., Ye, L., Peppers, J., Gallagher, K., & Kraus, J. E. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.10.037 · Cited by 93
Interleukin-22 Promotes Wound Repair in Diabetes by Improving Keratinocyte Pro-Healing Functions
Avitabile, S., Odorisio, T., Madonna, S., Eyerich, S., Guerra, L., Eyerich, K., Zambruno, G., Cavani, A., & Cianfarani, F. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.278 · Cited by 92
Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial: WBI-1001 as a novel topical treatment for atopic dermatitis
Bissonnette, R., Poulin, Y., Zhou, Y., Tan, J., Hong, H. C., Webster, J., Ip, W., Tang, L., & Lyle, M. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10775.x · Cited by 92
Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair
de Koning, H. D., van den Bogaard, E. H. J., Bergboer, J. G. M., Kamsteeg, M., van Vlijmen‐Willems, I. M. J. J., Hitomi, K., Henry, J., Simon, M., Takashita, N., Ishida‐Yamamoto, A., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10885.x · Cited by 91
Cynaropicrin attenuates UVB-induced oxidative stress via the AhR–Nrf2–Nqo1 pathway
Takei, K., Hashimoto‐Hachiya, A., Takahara, M., Tsuji, G., Nakahara, T., & Furue, M. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.02.007 · Cited by 88
Self-citation
Burden of atopic dermatitis in Japanese adults: Analysis of data from the 2013 National Health and Wellness Survey
Arima, K., Gupta, S., Gadkari, A. S., Hiragun, T., Kono, T., Katayama, I., Demiya, S., & Eckert, L. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14218 · Cited by 86
Functional Analysis of the Profilaggrin N-Terminal Peptide: Identification of Domains that Regulate Nuclear and Cytoplasmic Distribution
Pearton, D. J., Dale, B. A., & Presland, R. B. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01831.x · Cited by 85
Psoriasis and the TNF/IL23/IL17 axis
Furue, K., Ito, T., Tsuji, G., Kadono, T., & Furue, M. (2019) · Giornale Italiano di Dermatologia e Venereologia · doi:10.23736/s0392-0488.18.06202-8 · Cited by 84
Self-citation
Antioxidant cinnamaldehyde attenuates UVB-induced photoaging
Tanaka, Y., Uchi, H., & Furue, M. (2019) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2019.11.001 · Cited by 84
Self-citation
Evidence for Specific Proteolytic Cleavage of the N-Terminal Domain of Human Profilaggrin During Epidermal Differentiation
Presland, R. B., Kimball, J. R., Kautsky, M. B., Lewis, S. P., Lo, C. Y., & Dale, B. A. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12333356 · Cited by 82
Inhibition of aryl hydrocarbon receptor signaling and induction of NRF2-mediated antioxidant activity by cinnamaldehyde in human keratinocytes
Uchi, H., Yasumatsu, M., Morino-Koga, S., Mitoma, C., & Furue, M. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.10.003 · Cited by 82
Self-citation
Differential efficacy of biologic treatments targeting the TNF-α/IL-23/IL-17 axis in psoriasis and psoriatic arthritis
Furue, K., Ito, T., & Furue, M. (2018) · Cytokine · doi:10.1016/j.cyto.2018.08.025 · Cited by 82
Self-citation
Antioxidant soybean tar Glyteer rescues T‐helper‐mediated downregulation of filaggrin expression via aryl hydrocarbon receptor
Takei, K., Mitoma, C., Hashimoto‐Hachiya, A., Uchi, H., Takahara, M., Tsuji, G., Kido‐Nakahara, M., Nakahara, T., & Furue, M. (2015) · The Journal of Dermatology · doi:10.1111/1346-8138.12717 · Cited by 81
Self-citation
South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin
Thawer-Esmail, F., Jakaša, I., Todd, G., Wen, Y., Brown, S., Kroboth, K., Campbell, L., O’Regan, G. M., McLean, W. H. I., Irvine, A. D., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.053 · Cited by 79
IL-4 and IL-13 receptors: Roles in immunity and powerful vaccine adjuvants
Ranasinghe, C., Trivedi, S., Wijesundara, D. K., & Jackson, R. J. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.010 · Cited by 79
Differences in Involucrin Immunolabeling Within Cornified Cell Envelopes in Normal and Psoriatic Epidermis
Ishida‐Yamamoto, A., & Iizuka, H. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12665870 · Cited by 77
An ITAM-Syk-CARD9 signalling axis triggers contact hypersensitivity by stimulating IL-1 production in dendritic cells
Yasukawa, S., Miyazaki, Y., Yoshii, C., Nakaya, M., Ozaki, N., Toda, S., Kuroda, E., Ishibashi, K.-I., Yasuda, T., Natsuaki, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms4755 · Cited by 77
Self-citation
Loricrin: Past, Present, and Future
Ishitsuka, Y., & Roop, D. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072271 · Cited by 76
In a three-dimensional reconstructed human epidermis filaggrin-2 is essential for proper cornification
Pendaries, V., Lamer, M. L., Cau, L., Hansmann, B., Malaisse, J., Kežić, S., Serre, G., & Simon, M. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.29 · Cited by 75
2,3,7,8-Tetrachlorodibenzo-p-dioxin alters sebaceous gland cell differentiation in vitro
Ju, Q., Fimmel, S., Hinz, N., Stahlmann, R., Xia, L., & Zouboulis, C. C. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01204.x · Cited by 74
2,3,7,8-Tetrachlorodibenzo-p-dioxin Alters the Differentiation Pattern of Human Keratinocytes in Organotypic Culture
Loertscher, J. A., Sattler, C. A., & Allen‐Hoffmann, B. L. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9202 · Cited by 74
IL-24: A new player in the pathogenesis of pro-inflammatory and allergic skin diseases
Mitamura, Y., Nunomura, S., Furue, M., & Izuhara, K. (2020) · Allergology International · doi:10.1016/j.alit.2019.12.003 · Cited by 72
Self-citation
Efficacy and safety of topical WBI‐1001 in patients with mild to moderate psoriasis: results from a randomized double‐blind placebo‐controlled, phase II trial
Bissonnette, R., Bolduc, C., Maari, C., Nigen, S., Webster, J. M., Tang, L. Y. W., & Lyle, M. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04332.x · Cited by 69
Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system.
Murata, T., Taguchi, J., Puri, R. K., & Mohri, H. (1999) · PubMed · Cited by 68
Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis
Guttman‐Yassky, E., Ungar, B., Malik, K., Dickstein, D. R., Suprun, M., Estrada, Y. D., Xu, H., Peng, X., Oliva, M., Todd, D., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.027 · Cited by 67
Perillaldehyde inhibits AHR signaling and activates NRF2 antioxidant pathway in human keratinocytes
Fuyuno, Y., Uchi, H., Yasumatsu, M., Morino-Koga, S., Tanaka, Y., Mitoma, C., & Furue, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9524657 · Cited by 65
Self-citation
Primary role of barrier dysfunction in the pathogenesis of atopic dermatitis
Elias, P. M. (2018) · Experimental Dermatology · doi:10.1111/exd.13693 · Cited by 65
JAK1/3 inhibition preserves epidermal morphology in full‐thickness 3D skin models of atopic dermatitis and psoriasis
Clarysse, K., Pfaff, C. M., Marquardt, Y., Huth, L., Krohn, I. K., Kluwig, D., Lüscher, B., Gutermuth, J., & Baron, J. M. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15301 · Cited by 65
Keratinocyte-derived IL-24 plays a role in the positive feedback regulation of epidermal inflammation in response to environmental and endogenous toxic stressors
Jin, S. H., Choi, D., Chun, Y.-J., & Noh, M. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.08.019 · Cited by 62
Translocation of profilaggrin N-terminal domain into keratinocyte nuclei with fragmented DNA in normal human skin and loricrin keratoderma.
Ishida‐Yamamoto, A., Takahashi, H., Presland, R. B., Dale, B. A., & Iizuka, H. (1998) · PubMed · Cited by 62
IL-4 Augments IL-31/IL-31 Receptor Alpha Interaction Leading to Enhanced Ccl 17 and Ccl 22 Production in Dendritic Cells: Implications for Atopic Dermatitis
Miake, S., Tsuji, G., Takemura, M., Hashimoto‐Hachiya, A., Vu, Y. H., Furue, M., & Nakahara, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164053 · Cited by 61
Self-citation
The role of the OVOL1–OVOL2 axis in normal and diseased human skin
Tsuji, G., Ito, T., Chiba, T., Mitoma, C., Nakahara, T., Uchi, H., & Furue, M. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.02.005 · Cited by 60
Self-citation
Direct assessment of skin epithelial barrier by electrical impedance spectroscopy
Rinaldi, A. O., Morita, H., Wawrzyniak, P., Dreher, A., Grant, S., Svedenhag, P., & Akdiş, C. A. (2019) · Allergy · doi:10.1111/all.13824 · Cited by 60
In Utero Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Causes Accelerated Terminal Differentiation in Fetal Mouse Skin
Loertscher, J. A. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.2.465 · Cited by 59
Upregulation of FLG, LOR, and IVL Expression by Rhodiola crenulata Root Extract via Aryl Hydrocarbon Receptor: Differential Involvement of OVOL1
Hashimoto‐Hachiya, A., Tsuji, G., Murai, M., Yan, X., & Furue, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061654 · Cited by 59
Self-citation
Dual Oxidase 1 Induced by Th2 Cytokines Promotes STAT6 Phosphorylation via Oxidative Inactivation of Protein Tyrosine Phosphatase 1B in Human Epidermal Keratinocytes
Hirakawa, S., Saito, R., Ohara, H., Okuyama, R., & Aiba, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000791 · Cited by 57
Full Sequencing of the FLG Gene in Italian Patients with Atopic Eczema: Evidence of New Mutations, but Lack of an Association
Cascella, R., Cuzzola, V. F., Lepre, T., Galli, E., Moschese, V., Chini, L., Mazzanti, C., Fortugno, P., Novelli, G., & Giardina, E. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.398 · Cited by 57
Additive Effects of Ultraviolet B and Crude Coal Tar on Cutaneous Carcinogen Metabolism: Possible Relevance to the Tumorigenicity of the Goeckerman Regimen
Mukhtar, H., DelTito, B. J., Matgouranis, P. M., Das, M., Asokan, P., & Bickers, D. R. (1986) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12524446 · Cited by 56
Skin-infiltrating, interleukin-22–producing T cells differentiate pediatric psoriasis from adult psoriasis
Cordoro, K. M., Hitraya‐Low, M., Taravati, K., Sandoval, P. M., Kim, E., Sugarman, J., Pauli, M. L., Liao, W. J., & Rosenblum, M. D. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.05.017 · Cited by 56
Induction and activation of the aryl hydrocarbon receptor by IL-4 in B cells
Tanaka, G., Kanaji, S., Hirano, A., Arima, K., Shinagawa, A., Goda, C., Yasunaga, S., Ikizawa, K., Yanagihara, Y., Kubo, M., et al. (2005) · International Immunology · doi:10.1093/intimm/dxh260 · Cited by 55
Protective role of 6-formylindolo[3,2-b]carbazole (FICZ), an endogenous ligand for arylhydrocarbon receptor, in chronic mite-induced dermatitis
Mari, O. D. A., Uchi, H., Morino‐Koga, S., & Furue, M. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.02.014 · Cited by 53
Self-citation
The Interleukin-20 Cytokines in Intestinal Diseases
Niess, J. H., Hruz, P. L., & Kaymak, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01373 · Cited by 53
Significant correlation of serum IL-22 levels with CCL17 levels in atopic dermatitis
Hayashida, S., Uchi, H., Takeuchi, S., Esaki, H., Moroi, Y., & Furue, M. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.08.013 · Cited by 52
Self-citation
Lycopene treatment inhibits activation of Jak1/Stat3 and Wnt/β-catenin signaling and attenuates hyperproliferation in gastric epithelial cells
Park, B., Lim, J. W., & Kim, H. (2018) · Nutrition Research · doi:10.1016/j.nutres.2018.07.010 · Cited by 52
C/EBPα and C/EBPβ Are Required for Sebocyte Differentiation and Stratified Squamous Differentiation in Adult Mouse Skin
House, J. S., Zhu, S., Ranjan, R., Linder, K. E., & Smart, R. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009837 · Cited by 51
Chloracne and Hyperpigmentation Caused by Exposure to Hazardous Aryl Hydrocarbon Receptor Ligands
Furue, M., & Tsuji, G. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16234864 · Cited by 51
Self-citation
Filaggrin loss-of-function mutations are not a predisposing factor for atopic dermatitis in an Ishigaki Island under subtropical climate
Sasaki, T., Furusyo, N., Shiohama, A., Takeuchi, S., Nakahara, T., Uchi, H., Hirota, T., Tamari, M., Shimizu, N., Ebihara, T., et al. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.06.004 · Cited by 50
Self-citation
Antioxidant Opuntia ficus-indica Extract Activates AHR-NRF2 Signaling and Upregulates Filaggrin and Loricrin Expression in Human Keratinocytes
Nakahara, T., Mitoma, C., Hashimoto-Hachiya, A., Takahara, M., Tsuji, G., Uchi, H., Yan, X., Hachisuka, J., Chiba, T., Esaki, H., et al. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2014.3396 · Cited by 49
Self-citation
Filaggrin 2 Deficiency Results in Abnormal Cell-Cell Adhesion in the Cornified Cell Layers and Causes Peeling Skin Syndrome Type A
Mohamad, J., Sarig, O., Godsel, L. M., Peled, A., Malchin, N., Bochner, R., Vodo, D., Rabinowitz, T., Pavlovsky, M., Taiber, S., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.04.032 · Cited by 49
The S100 proteins in epidermis: Topology and function
Leśniak, W., & Graczyk‐Jarzynka, A. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.09.015 · Cited by 48
Antioxidant Artemisia princeps Extract Enhances the Expression of Filaggrin and Loricrin via the AHR/OVOL1 Pathway
Hirano, A., Goto, M., Mitsui, T., Hashimoto-Hachiya, A., Tsuji, G., & Furue, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091948 · Cited by 48
Self-citation
Cytochrome P4501-inhibiting chemicals amplify aryl hydrocarbon receptor activation and IL-22 production in T helper 17 cells
Schiering, C., Vonk, A., Das, S., Stockinger, B., & Wincent, E. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.031 · Cited by 48
MAP17 is associated with the T‐helper cell cytokine‐induced down‐regulation of filaggrin transcription in human keratinocytes
Noh, M., Yeo, H., Ko, J., Kim, H. K., & Lee, C. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00902.x · Cited by 47
Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression
Sun, D., Yeh, C., So, E. C., Wang, L.-Y., Wei, T.-S., Chang, M., & Hsing, C. (2013) · Cytokine · doi:10.1016/j.cyto.2013.03.017 · Cited by 46
Galactomyces fermentation filtrate prevents T helper 2‐mediated reduction of filaggrin in an aryl hydrocarbon receptor‐dependent manner
Takei, K., Mitoma, C., Hashimoto‐Hachiya, A., Takahara, M., Tsuji, G., Nakahara, T., & Furue, M. (2015) · Clinical and Experimental Dermatology · doi:10.1111/ced.12635 · Cited by 45
Self-citation
Genetic Variants of the IL22 Promoter Associate to Onset of Psoriasis before Puberty and Increased IL-22 Production in T Cells
Nikamo, P., Cheuk, S., Lysell, J., Enerbäck, C., Bergh, K., Xu, N., Eidsmo, L., & Ståhle, M. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.5 · Cited by 45
Human stratum corneum proteomics reveals cross‐linking of a broad spectrum of proteins in cornified envelopes
Karim, N., Phinney, B. S., Salemi, M., Wu, P., Naeem, M., & Rice, R. H. (2019) · Experimental Dermatology · doi:10.1111/exd.13925 · Cited by 44
IL‐22‐producing CD4+ T cells: Middle‐men between the immune system and its environment
Trifari, S., & Spits, H. (2010) · European Journal of Immunology · doi:10.1002/eji.201040848 · Cited by 43
Potential role of the OVOL1–OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma
Ito, T., Tsuji, G., Ohno, F., Nakahara, T., Uchi, H., & Furue, M. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.169 · Cited by 43
Self-citation
Antioxidative Phytochemicals Accelerate Epidermal Terminal Differentiation via the AHR-OVOL1 Pathway: Implications for Atopic Dermatitis
Furue, M., Hashimoto‐Hachiya, A., & Tsuji, G. (2018) · Acta Dermato Venereologica · doi:10.2340/00015555-3003 · Cited by 43
Self-citation
The Distal and Proximal Regulatory Regions of the Involucrin Gene Promoter have Distinct Functions and Are Required for In Vivo Involucrin Expression
Crish, J. F., Gopalakrishnan, R., Bone, F., Gilliam, A. C., & Eckert, R. L. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700019 · Cited by 42
Alteration of keratinocyte differentiation and senescence by the tumor promoter dioxin⋆
Ray, S. S. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00277-1 · Cited by 42
Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study
Bissonnette, R., Vasist, L., Bullman, J., Collingwood, T. S., Chen, G., & Maeda‐Chubachi, T. (2018) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.439 · Cited by 42
Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Regulates Epidermal Keratinization under Psoriatic Skin Inflammation
Ogawa, T., Ishitsuka, Y., Inoue, S., Nakamura, Y., Saito, A., Okiyama, N., Fujisawa, Y., Furuta, J., Watanabe, R., & Fujimoto, M. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.10.022 · Cited by 42
Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes
Ulzii, D., Kido‐Nakahara, M., Nakahara, T., Tsuji, G., Furue, K., Hashimoto‐Hachiya, A., & Furue, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133324 · Cited by 41
Self-citation
Tussilagonone Ameliorates Psoriatic Features in Keratinocytes and Imiquimod-Induced Psoriasis-Like Lesions in Mice via NRF2 Activation
Lee, J., Song, K., Hiebert, P., Werner, S., Kim, T., & Kim, Y. S. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.12.008 · Cited by 41
NRF2 Activation Inhibits Both TGF‐ β 1‐ and IL‐13‐Mediated Periostin Expression in Fibroblasts: Benefit of Cinnamaldehyde for Antifibrotic Treatment
Mitamura, Y., Murai, M., Mitoma, C., & Furue, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2475047 · Cited by 40
Self-citation
Skin barrier damage after exposure to paraphenylenediamine
Meisser, S. S., Altunbulakli, C., Bandier, J., Opstrup, M. S., Castro-Giner, F., Akdiş, M., Bonefeld, C. M., Johansen, J. D., & Akdiş, C. A. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.023 · Cited by 40
Implications of IL-13Rα2 in atopic skin inflammation
Furue, M., Ulzii, D., Nakahara, T., Tsuji, G., Furue, K., Hashimoto‐Hachiya, A., & Kido‐Nakahara, M. (2020) · Allergology International · doi:10.1016/j.alit.2020.01.005 · Cited by 40
Self-citation
Glyteer, Soybean Tar, Impairs IL-4/Stat6 Signaling in Murine Bone Marrow-Derived Dendritic Cells: The Basis of Its Therapeutic Effect on Atopic Dermatitis
Takemura, M., Nakahara, T., Hashimoto‐Hachiya, A., Furue, M., & Tsuji, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041169 · Cited by 38
Self-citation
Role of nuclear factor E2-related factor 2 (Nrf2) in epidermal differentiation
Lee, Y., Shin, J., Jang, S., Choi, D.-K., Seo, M.-S., Kim, H.-R., Sohn, K., Im, M., Seo, Y., Lee, J., et al. (2014) · Archives of Dermatological Research · doi:10.1007/s00403-014-1470-x · Cited by 36
A Novel Role of the NRF2 Transcription Factor in the Regulation of Arsenite-Mediated Keratin 16 Gene Expression in Human Keratinocytes
Endo, H., Sugioka, Y., Nakagi, Y., Saijo, Y., & Yoshida, T. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.10696 · Cited by 35
Health‐care resource use and current treatment of adult atopic dermatitis patients in Japan: A retrospective claims database analysis
Igarashi, A., Fujita, H., Arima, K., Inoue, T., Dorey, J., Fukushima, A., & Taguchi, Y. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14947 · Cited by 35
Expression of Cornified Envelope Proteins in Skin and Its Relationship with Atopic Dermatitis Phenotype
Trzeciak, M., Sakowicz‐Burkiewicz, M., Wesserling, M., Dobaczewska, D., Gleń, J., Nowicki, R. J., & Pawełczyk, T. (2016) · Acta Dermato Venereologica · doi:10.2340/00015555-2482 · Cited by 33
Phenotypes of atopic dermatitis identified by cluster analysis in early childhood
Seo, E., Yoon, J., Jung, S., Lee, J., Lee, B. H., & Yu, J. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14714 · Cited by 33
IL-17 promotes keratinocyte proliferation via the downregulation of C/EBPα
Ma, W., JIA, K., & Zhang, Y. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2939 · Cited by 32
Activation of the OVOL1-OVOL2 Axis in the Hair Bulb and in Pilomatricoma
Ito, T., Tsuji, G., Ohno, F., Uchi, H., Nakahara, T., Hashimoto‐Hachiya, A., Yoshida, Y., Yamamoto, O., Oda, Y., & Furue, M. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.12.013 · Cited by 31
Self-citation
Baicalein Inhibits Benzo[a]pyrene-Induced Toxic Response by Downregulating Src Phosphorylation and by Upregulating NRF2-HMOX1 System
Tanaka, Y., Ito, T., Tsuji, G., & Furue, M. (2020) · Antioxidants · doi:10.3390/antiox9060507 · Cited by 31
Self-citation
Therapeutic Agents with AHR Inhibiting and NRF2 Activating Activity for Managing Chloracne
Furue, M., Fuyuno, Y., Mitoma, C., Uchi, H., & Tsuji, G. (2018) · Antioxidants · doi:10.3390/antiox7070090 · Cited by 30
Self-citation
IL-19 Up-Regulates Mucin 5AC Production in Patients With Chronic Rhinosinusitis via STAT3 Pathway
Lai, X., Li, X., Chang, L., Chen, X., Huang, Z., Bao, H., Huang, J., Yang, L., Wu, X., Wang, Z., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01682 · Cited by 30
Igalan from Inula helenium (L.) suppresses the atopic dermatitis-like response in stimulated HaCaT keratinocytes via JAK/STAT3 signaling
Dao, T. T. P., Song, K., Kim, J. Y., & Kim, Y. S. (2020) · Inflammation Research · doi:10.1007/s00011-020-01322-4 · Cited by 30
Filaggrin loss‐of‐function mutations and levels of filaggrin degradation products in adult patients with atopic dermatitis in Croatia
Tončić, R. J., Kežić, S., Jakaša, I., Hadžavdić, S. L., Balić, A., Petković, M., Pavičić, B., Zuzul, K., & Marinović, B. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16232 · Cited by 29
Non-invasive evaluation of atopic dermatitis based on redox status using in vivo dynamic nuclear polarization magnetic resonance imaging
Eto, H., Tsuji, G., Chiba, T., Furue, M., & Hyodo, F. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.043 · Cited by 28
Self-citation
Long‐term clinical efficacy and safety of secukinumab for Japanese patients with psoriasis: A single‐center experience
Momose, M., Asahina, A., Umezawa, Y., & Nakagawa, H. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14145 · Cited by 28
Recent Positive Selection in Genes of the Mammalian Epidermal Differentiation Complex Locus
Goodwin, Z. A., & Strong, C. D. G. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2016.00227 · Cited by 27
Microbiome analysis of forehead skin in patients with atopic dermatitis and healthy subjects: Implication of Staphylococcus and Corynebacterium
Furue, M., Iida, K., Imaji, M., & Nakahara, T. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14486 · Cited by 27
Self-citation
Measurement of trihydroxy-linoleic acids in stratum corneum by tape-stripping: Possible biomarker of barrier function in atopic dermatitis
Chiba, T., Nakahara, T., Kohda, F., Ichiki, T., Manabe, M., & Furue, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210013 · Cited by 27
Self-citation
Current skin symptoms of Yusho patients exposed to high levels of 2,3,4,7,8-pentachlorinated dibenzofuran and polychlorinated biphenyls in 1968
Mitoma, C., Mine, Y., Utani, A., Imafuku, S., Muto, M., Akimoto, T., Kanekura, T., Furue, M., & Uchi, H. (2015) · Chemosphere · doi:10.1016/j.chemosphere.2015.03.070 · Cited by 25
Self-citation

Flagged first, then by citations

5 of the 231 references couldn’t be matched to a known paper.

Sorted by citations

Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis
Fang, Z., Pan, T., Li, L., Wang, H., Zhu, J., Zhang, H., Zhao, J., Chen, W., & Lu, W. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2044723 · Cited by 273
Gut Microbiota, Probiotics, and Their Interactions in Prevention and Treatment of Atopic Dermatitis: A Review
Fang, Z., Li, L., Zhang, H., Zhao, J., Lu, W., & Chen, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720393 · Cited by 200
Particulate matter causes skin barrier dysfunction.
Kim, B. E., Kim, J., Goleva, E., Berdyshev, E., Lee, J., Vang, K. A., Lee, U. H., Han, S., Leung, S., Hall, C. F., et al. (2021) · JCI insight · doi:10.1172/jci.insight.145185 · Cited by 173
“barrier proteins such as FLG and LOR (42, 56).”
BackgroundInfluential
Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic Dermatitis
Furue, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113741 · Cited by 161
Self-citation
miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
Jiao, P., Wang, X.-P., Luoreng, Z.-M., Yang, J., Jia, L., Ma, Y., & Wei, D.-W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59876 · Cited by 151

See all 424

Authors: Furue, M.
Affiliations: Kyushu University (JP)
Corresponding author: Furue, Masutaka
ORCID: Furue, Masutaka
Venue: International Journal of Molecular Sciences
Publisher: MDPI AG
Published: 2020-07-29
Volume: 21
Issue: 15
Pages: 5382
ISSN: 1422-0067 (ISSN-L)
DOI: 10.3390/ijms21155382
PMC: PMC7432778
OpenAlex: W3046068546
Cited by: 419
References: 231
Citations by year: 2026: 83 · 2025: 82 · 2024: 81 · 2023: 74 · 2022: 64 · 2021: 32 · 2020: 2
FWCI: 7.19
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (vor)
Locations: International Journal of Molecular Sciences (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: Ministry of Health, Labour and Welfare (H30-Shokuhin-Shitei-005)
Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (C, FAG0K08692)
Topics: Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
Keywords: atopic dermatitis, filaggrin, loricrin, involucrin, skin barrier dysfunction, IL-4, IL-13, IL-17A, IL-22, aryl hydrocarbon receptor, Nrf2, STAT6, STAT3, oxidative stress, coal tar, tapinarof, AhR agonists
MeSH terms: Filaggrin Proteins, Interleukin-22, Antioxidants, Coal Tar, Dermatitis, Atopic, Gene Expression Regulation, Humans, Interleukins, Membrane Proteins, S100 Proteins, Protein Precursors, Resorcinols, Skin, Stilbenes, Tars, Signal Transduction, Interleukin-4, Receptors, Aryl Hydrocarbon, Oxidative Stress, Interleukin-13, Interleukin-17, STAT3 Transcription Factor, STAT6 Transcription Factor, NF-E2-Related Factor 2, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks